BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Richner M, Ferreira N, Dudele A, Jensen TS, Vaegter CB, Gonçalves NP. Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy. Front Neurosci 2018;12:1038. [PMID: 30692907 DOI: 10.3389/fnins.2018.01038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Stubbs EB Jr. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies. Exp Neurol 2020;331:113385. [PMID: 32562668 DOI: 10.1016/j.expneurol.2020.113385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kuthati Y, Navakanth Rao V, Busa P, Tummala S, Davuluri Venkata Naga G, Wong CS. Scope and Applications of Nanomedicines for the Management of Neuropathic Pain. Mol Pharm 2020;17:1015-27. [PMID: 32142287 DOI: 10.1021/acs.molpharmaceut.9b01027] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ubogu EE. Biology of the human blood-nerve barrier in health and disease. Exp Neurol 2020;328:113272. [PMID: 32142802 DOI: 10.1016/j.expneurol.2020.113272] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
4 Hong OK, Lee SS, Yoo SJ, Choi SH, Lee MK, Cha BY, Kim MK, Baek KH, Song KH, Kwon HS. Effects of DA-9801 on the inflammation and apoptosis induced by angiotensin II in human dermal microvascular endothelial cells. J Pharmacol Sci 2021;145:52-9. [PMID: 33357779 DOI: 10.1016/j.jphs.2020.10.008] [Reference Citation Analysis]
5 Velayutham V, Benitez-Aguirre PZ, Liew G, Wong TY, Jenkins AJ, Craig ME, Donaghue KC. Baseline extended zone retinal vascular calibres associate with sensory nerve abnormalities in adolescents with type 1 diabetes: A prospective longitudinal study. Diabet Med 2021;:e14662. [PMID: 34324736 DOI: 10.1111/dme.14662] [Reference Citation Analysis]
6 Samocha-Bonet D, Wu B, Ryugo DK. Diabetes mellitus and hearing loss: A review. Ageing Res Rev 2021;71:101423. [PMID: 34384902 DOI: 10.1016/j.arr.2021.101423] [Reference Citation Analysis]
7 Nam JW, Lee MJ, Kim HJ. Diagnostic Efficacy of 18F-FDG PET/MRI in Peripheral Nerve Injury Models. Neurochem Res 2019;44:2092-102. [PMID: 31377996 DOI: 10.1007/s11064-019-02846-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Selim OA, Lakhani S, Midha S, Mosahebi A, Kalaskar DM. Three-Dimensional Engineered Peripheral Nerve: Toward a New Era of Patient-Specific Nerve Repair Solutions. Tissue Eng Part B Rev 2021. [PMID: 33593147 DOI: 10.1089/ten.TEB.2020.0355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ben-Kraiem A, Sauer RS, Norwig C, Popp M, Bettenhausen AL, Atalla MS, Brack A, Blum R, Doppler K, Rittner HL. Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy. J Mol Med (Berl) 2021;99:1237-50. [PMID: 34018017 DOI: 10.1007/s00109-021-02091-1] [Reference Citation Analysis]
10 Chen JT, Schmidt L, Schürger C, Hankir MK, Krug SM, Rittner HL. Netrin-1 as a Multitarget Barrier Stabilizer in the Peripheral Nerve after Injury. Int J Mol Sci 2021;22:10090. [PMID: 34576252 DOI: 10.3390/ijms221810090] [Reference Citation Analysis]
11 Milora KA, Rall GF. Interferon Control of Neurotropic Viral Infections. Trends Immunol 2019;40:842-56. [PMID: 31439415 DOI: 10.1016/j.it.2019.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Preguiça I, Alves A, Nunes S, Gomes P, Fernandes R, Viana SD, Reis F. Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy.Nutrients. 2020;12. [PMID: 31963709 DOI: 10.3390/nu12010250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
13 Chatterjee P, Srivastava AK, Kumar DA, Chakrawarty A, Khan MA, Ambashtha AK, Kumar V, De Taboada L, Dey AB. Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial. BMC Geriatr 2019;19:218. [PMID: 31405365 DOI: 10.1186/s12877-019-1237-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Roy S, Kim D. Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2021;82:100903. [PMID: 32950677 DOI: 10.1016/j.preteyeres.2020.100903] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
15 Adler M, Pellett S, Sharma SK, Lebeda FJ, Dembek ZF, Mahan MA. Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury. Microorganisms 2022;10:886. [DOI: 10.3390/microorganisms10050886] [Reference Citation Analysis]
16 Jafarnezhadgero A, Mamashli E, Granacher U. An Endurance-Dominated Exercise Program Improves Maximum Oxygen Consumption, Ground Reaction Forces, and Muscle Activities in Patients With Moderate Diabetic Neuropathy. Front Physiol 2021;12:654755. [PMID: 33868023 DOI: 10.3389/fphys.2021.654755] [Reference Citation Analysis]
17 Morag Y, Altshuler D, Udager K, Yang LC. Vascular compromise in a torsed transposed ulnar nerve case in support of intravenous contrast administration. Clin Imaging 2021;70:118-23. [PMID: 33157368 DOI: 10.1016/j.clinimag.2020.10.008] [Reference Citation Analysis]
18 Ugrenović S, Jovanović I, Kundalić B, Stojanović V, Pavlović M, Antović A, Milić M, Kokoris JČ. Morphometric analysis of the epineurial and endoneurial blood vessels of the human sciatic nerve in relation to aging. Tissue Cell 2020;66:101389. [PMID: 32933712 DOI: 10.1016/j.tice.2020.101389] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev 2021;101:259-301. [PMID: 32584191 DOI: 10.1152/physrev.00045.2019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
20 Avraham O, Feng R, Ewan EE, Rustenhoven J, Zhao G, Cavalli V. Profiling sensory neuron microenvironment after peripheral and central axon injury reveals key pathways for neural repair. Elife 2021;10:e68457. [PMID: 34586065 DOI: 10.7554/eLife.68457] [Reference Citation Analysis]
21 Rawat A, Morrison BM. Metabolic Transporters in the Peripheral Nerve-What, Where, and Why? Neurotherapeutics 2021. [PMID: 34773210 DOI: 10.1007/s13311-021-01150-2] [Reference Citation Analysis]
22 Deng Z, Wang M, Fan YH, Huang R, Rao Y, Mai X, Liu M. A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy. Medicine (Baltimore) 2019;98:e17618. [PMID: 31626140 DOI: 10.1097/MD.0000000000017618] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Takeshita Y, Sato R, Kanda T. Blood-Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model. Int J Mol Sci 2020;22:E62. [PMID: 33374622 DOI: 10.3390/ijms22010062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Chandler E, Brown M, Wintergerst K, Doll E. Treatment-Induced Neuropathy of Diabetes (TIND) in Pediatrics: A Case Report and Review of the Literature. The Journal of Clinical Endocrinology & Metabolism 2020;105:395-8. [DOI: 10.1210/clinem/dgz067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Alsaloum M, Higerd GP, Effraim PR, Waxman SG. Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat Rev Neurol 2020;16:689-705. [PMID: 33110213 DOI: 10.1038/s41582-020-00415-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
26 Collares-Buzato CB, Carvalho CP. Is type 2 diabetes mellitus another intercellular junction-related disorder? Exp Biol Med (Maywood) 2022;:15353702221090464. [PMID: 35466731 DOI: 10.1177/15353702221090464] [Reference Citation Analysis]
27 Chai AB, Hartz AMS, Gao X, Yang A, Callaghan R, Gelissen IC. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models. Int J Mol Sci 2020;22:E246. [PMID: 33383667 DOI: 10.3390/ijms22010246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Ravichandran S, Srivastav S, Kamble PH, Chambial S, Shukla R, Sharma P, Sharma RK. VEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: A cross-sectional study at a tertiary care center. J Family Med Prim Care 2019;8:3185-90. [PMID: 31742140 DOI: 10.4103/jfmpc.jfmpc_537_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Asiri MMH, Engelsman S, Eijkelkamp N, Höppener JWM. Amyloid Proteins and Peripheral Neuropathy. Cells 2020;9:E1553. [PMID: 32604774 DOI: 10.3390/cells9061553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ferreira N, Gonçalves NP, Jan A, Jensen NM, van der Laan A, Mohseni S, Vægter CB, Jensen PH. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. Acta Neuropathol Commun 2021;9:31. [PMID: 33632316 DOI: 10.1186/s40478-021-01131-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
31 Forrester JV, Kuffova L, Delibegovic M. The Role of Inflammation in Diabetic Retinopathy. Front Immunol. 2020;11:583687. [PMID: 33240272 DOI: 10.3389/fimmu.2020.583687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
32 Xiong Q, Liu J, Xu Y. Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications. Int J Endocrinol 2019;2019:9691345. [PMID: 31737070 DOI: 10.1155/2019/9691345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
33 Pai YW, Tang CL, Lin CH, Lin SY, Lee IT, Chang MH. Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin. Diabetes Metab 2021;47:101158. [PMID: 32413414 DOI: 10.1016/j.diabet.2020.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Horton WB, Barrett EJ. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocr Rev 2021;42:29-55. [PMID: 33125468 DOI: 10.1210/endrev/bnaa025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
35 Gonçalves NP, Jager SE, Richner M, Murray SS, Mohseni S, Jensen TS, Vaegter CB. Schwann cell p75 neurotrophin receptor modulates small fiber degeneration in diabetic neuropathy. Glia 2020;68:2725-43. [PMID: 32658363 DOI: 10.1002/glia.23881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Lanigan LG, Russell DS, Woolard KD, Pardo ID, Godfrey V, Jortner BS, Butt MT, Bolon B. Comparative Pathology of the Peripheral Nervous System. Vet Pathol 2021;58:10-33. [PMID: 33016246 DOI: 10.1177/0300985820959231] [Reference Citation Analysis]
37 Cernea S, Raz I. Management of diabetic neuropathy. Metabolism 2021;123:154867. [PMID: 34411554 DOI: 10.1016/j.metabol.2021.154867] [Reference Citation Analysis]